Back to search

Article

Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia condition

2022-11-22

Abstract excerpt

<h4>Background: </h4> & Aims: Cisplatin (DDP)-based chemotherapy is commonly adopted as the first-line treatment for patients with oesophageal squamous cell carcinoma (OSCC), but the high rate of drug resistance limits its clinical application, and the underlying mechanisms remain unclear. The aims of this study is to elucidate the role of abnormal signal transmission and metabolism in chemoresistance of OSCC unde...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
63f25ce0-ef9a-57c0-82b5-ec50654a5f6e
DOI
10.21203/rs.3.rs-2269651/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia conditionDOI 10.21203/rs.3.rs-2269651/v1
Select a neighboring publication to make it the new centre.